New Releases from NCBI BookshelfLinzagolix for treating moderate to severe symptoms of uterine fibroids.Linzagolix for treating moderate to severe symptoms of uterine fibroids.
Post Content
Uncategorized
Uncategorized
New Releases from NCBI BookshelfPembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma.Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma.
Post Content
Uncategorized
New Releases from NCBI BookshelfCombating Antimicrobial Resistance During the COVID-19 Pandemic: Perceived Risks and Protective Practices: Report [Internet].Combating Antimicrobial Resistance During the COVID-19 Pandemic: Perceived Risks and Protective Practices: Report [Internet].
The COVID-19 pandemic significantly disrupted efforts to combat antimicrobial resistance (AMR), undoing much of the progress achieved in recent years.
Uncategorized
New Releases from NCBI BookshelfEnabling 21st Century Applications for Cancer Surveillance Through Enhanced Registries and Beyond: Proceedings of a Workshop [Prepublication Draft].Enabling 21st Century Applications for Cancer Surveillance Through Enhanced Registries and Beyond: Proceedings of a Workshop [Prepublication Draft].
Population-based cancer surveillance has a pivotal role in assessing the nation’s progress in cancer control and helps inform research and
Uncategorized
New Releases from NCBI BookshelfDrug Development [Internet].Drug Development [Internet].
The cost of bringing a medical product to the U.S. market has been increasing and clinical trials constitute a large
